The Indian diabetes care drugs market is anticipated to grow at a significant CAGR during the forecast period (2020-2026). The key factor that drives the growth of the market is the rising prevalence of diabetes in the country. India has the second-largest number of adults with diabetes globally. As per the IDF, there were 77 million adults (20-79 years) suffering from diabetes in 2019.
Browse the full report description India Diabetes Care Drugs Market Size, Share & Trends Analysis Report by Drug Class (Insulins, Non-Insulin Injectable Drugs, Oral Anti-Diabetic Drugs, and Combination Drugs) Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/india-diabetes-care-drugs-market
Moreover, the rising aging population is also among one of the key drivers of the Indian diabetes care drugs industry. As per the World Bank, there is more than 83 million elderly population (65 and above) that is over 6.1% of the total population. As older peoples are more prone to diseases such as diabetes, joint pain among others which creates scope for the market.
As per the projections by the IDF, the diabetes prevalence is likely to reach more than 101.0 million in 2030 and further reach 134.2 million in 2045. Furthermore, the increased spending on healthcare and particularly diabetes is also likely to support the growth of the market over the forecast period. As per the World Economic Forum (WEF), the GDP of the country in 2018 was $2.9 trillion. According to the National Health Portal of India, India spends only 1.02% of its GDP on public health. The presence of the key players also supports the growth of the market over the forecast period.
Market Coverage
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
India Diabetes Care Drugs Market – Segmentation
By Drug Class
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/india-diabetes-care-drugs-market